FM AUGUST 2018 ISSUE1 - digital edition


news updates

due to low cost and free

availability. The false positive

rate in the endemic areas is

also high.

Antigen detecting rapid

diagnostic tests and blood

smear examination are reliable

tests for malaria diagnosis,

according to the guidance.



wins MedTech




edGenome, a leading

genomics driven

research and diagnostics

company, announced that its

OncoPep platform was named

the winner of the 2018

MedTech Breakthrough

Awards for ‘Best Overall

Genomics Solution’.

An advanced genomicsbased

solution designed

to accelerate cancer

immune-oncology research,

OncoPept platform is used

by researchers to help

identify biomarkers aimed

at delivering personalized

therapies, including

more durable, improved

and responsive cancer

immunotherapy treatments.

using NGS (Next Generation

Sequencing) based solutions.

The MedTech Breakthrough

Awards recognize the top

companies, people, platforms

and products in the health,

fitness and medical technology

industries today.

AAPI urges US

Congress to cut

Rx drug costs


merican Association of

Physicians of Indian

Origin (AAPI) has urged the

US Congress to pass the

necessary legislation to lower

the cost of prescription

drugs, a major issue of

concern for patients in the

United States.

The exorbitant cost of

prescription drugs is a critical

health care issue, as some lifesaving

drugs are too expensive

for many patients, said a

memorandum submitted by

AAPI to the lawmakers.

today to prevent increased

health care costs in the

future,” said AAPI, which is

the representative body of

Indian American physicians

in the US.

AAPI also emphasized the

need for immigration reform.

Changes to H1 & J1 visa rules

have created a backlog in

the issue of green cards and

visas to physicians as they are

restricted to serve in rural and

underserved areas.

The US is facing a chronic

physician shortage, which will

only be exacerbated in the

years ahead as more baby

boomers retire. AAPI said the

Congress can act by passing

legislation to add 15,000

more residency slots, which

will help to train up to 45,000

more doctors in the next

two decades.

Go ahead with

typhoid conjugate

vaccine: WHO


he World Health

Organization (WHO) has

recommended the

introduction of typhoid

conjugate vaccine (TCV) for

infants and children over six

months of age in typhoidendemic


The recommendation is based

on a review of evidence on

TCVs by WHO’s Strategic

Advisory Group of Experts

(SAGE) on Immunization in

October 2017. The group

considered data on vaccine

safety, efficacy, feasibility, and

affordability, as well as growing

rates of drug-resistant typhoid.

“Studies have shown that the

typhoid conjugate vaccine is

safe, effective, and can provide

protection for infants and

children under two years of age,

unlike the previously available

typhoid vaccines,” said Dr

Adwoa Bentsi-Enchill, medical

officer of the Department of

Immunization, Vaccines and

Biologicals at WHO.

TCV provides longer-lasting

protection, and requires fewer

doses compared to earlier

typhoid vaccines. It is suitable for

children under two years of age.

Vaccine introduction should

be accompanied by catch-up

vaccination campaigns for

children up to 15 years of age in

endemic countries, the position

paper recommended

It leverages on a novel T cell

receptor binding algorithm to

predict personalised cancer

vaccine candidates, and

provides a high-throughput

multi-dimensional view of the

tumour microenvironment

“As physicians, we want to

ensure that the medicines

patients need are affordable

and will be taken, to ensure

a high quality of life, the

reduction of chronic ailments,

and effective treatment


More magazines by this user
Similar magazines